Differences Between Women With COVID-19 and Long Covid

NCT05669235 | Completed

• 1 other identifier: OBS_LCOVID
• Study Type: observational
• Target: 23
• Locations: 1 country
• Sites: 1

Brief Summary

The coronavirus disease of 2019 (COVID-19) has infected more than 630 million people and resulted in more than 6.5 million deaths worldwide. Among the possible sequelae of the virus, a disorder called long COVID has shown to affect about 10% of those infected, mostly adult women, without comorbidities. Long COVID corresponds to a multisystemic syndrome following the acute period of the disease, in which the person maintains persistent symptoms such as fatigue, dyspnea, cough, memory loss, muscle and joint pain, among others. Now that time has passed, it is necessary to verify why there are women who present symptoms of long covid and others do not.

Conditions

COVID-19

Keywords

COVID-19; Long covid; Women

Outcome Measures

Primary Outcomes (1)

• Fatigue Assessment Scale

  Scale that measures fatigue, made up of 10 items rated from 1 to 5: 1. Never 2. Sometimes (think of a frequency of once a month or less, for example) 3. Regularly (for example, a couple of times a month) 4. often (think for example every week) 5. always (every day)

  Baseline

Secondary Outcomes (6)

• Modified Medical Research Council Dyspnea Scale

  Baseline

• Quality of life (EQ-5D)

  Baseline

• Perceived Stress Scale (PSS)

  Baseline

• Hospital Anxiety and Depression Scale (HADS)

  Baseline

• Inventario de Depresión de Beck (BDI-2)

  Baseline

Study Arms (2)

Long covid

Women who present symptoms after suffering from COVID-19, consistent with long covid.

Diagnostic Test: Questionnaires

Covid

Women who have passed COVID-19 without consequences.

Diagnostic Test: Questionnaires

Interventions

Questionnaires DIAGNOSTIC_TEST

A series of questionnaires will be carried out that assess both respiratory problems, depression and strength.

Covid; Long covid

Eligibility Criteria

• Age: 18 Years - 65 Years
• Gender Eligibility Details: Women
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Women who have suffered from COVID-19 who have or have not had symptoms since then.

You may qualify if:

• Women between 18 and 65 years
• That they have passed COVID-19 at least once.
• Whether or not they have symptoms secondary to COVID-19.

You may not qualify if:

• They do not want to sign the informed consent.

Sponsors & Collaborators

• University of Valencia: lead

Study Sites (1)

University of Valencia

Valencia, 46010, Spain

Location

MeSH Terms

Conditions

COVID-19; Post-Acute COVID-19 Syndrome

Condition Hierarchy (Ancestors)

Pneumonia, Viral; Pneumonia; Respiratory Tract Infections; Infections; Virus Diseases; Coronavirus Infections; Coronaviridae Infections; Nidovirales Infections; RNA Virus Infections; Lung Diseases; Respiratory Tract Diseases; Post-Infectious Disorders; Chronic Disease; Disease Attributes; Pathologic Processes; Pathological Conditions, Signs and Symptoms

Study Design

• Study Type: observational
• Observational Model: CASE CONTROL
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Assistant professor

Study Record Dates

• First Submitted: December 29, 2022
• First Posted: December 30, 2022
• Study Start: December 29, 2022
• Primary Completion: February 28, 2023
• Study Completion: October 1, 2023
• Last Updated: October 16, 2023

Record last verified: 2023-10

Data Sharing

• IPD Sharing: Will not share

Locations

ES (1)